BRCA-deficient mouse mammary tumor organoids to study cancer-drug resistance.
about
New tools for old drugs: Functional genetic screens to optimize current chemotherapy.The CST Complex Mediates End Protection at Double-Strand Breaks and Promotes PARP Inhibitor Sensitivity in BRCA1-Deficient Cells.The Mouse Hospital and Its Integration in Ultra-Precision Approaches to Cancer CareOrganoid technology and applications in cancer researchThe shieldin complex mediates 53BP1-dependent DNA repair
P2860
BRCA-deficient mouse mammary tumor organoids to study cancer-drug resistance.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
BRCA-deficient mouse mammary tumor organoids to study cancer-drug resistance.
@en
BRCA-deficient mouse mammary tumor organoids to study cancer-drug resistance.
@nl
type
label
BRCA-deficient mouse mammary tumor organoids to study cancer-drug resistance.
@en
BRCA-deficient mouse mammary tumor organoids to study cancer-drug resistance.
@nl
prefLabel
BRCA-deficient mouse mammary tumor organoids to study cancer-drug resistance.
@en
BRCA-deficient mouse mammary tumor organoids to study cancer-drug resistance.
@nl
P2093
P2860
P50
P356
P1433
P1476
BRCA-deficient mouse mammary tumor organoids to study cancer-drug resistance.
@en
P2093
Alexandra A Duarte
Ewa Gogola
Hans Clevers
Jos Jonkers
Julia M Houthuijzen
Julian R de Ruiter
Marieke van de Ven
Piet Borst
Sohvi Blatter
Stefano Annunziato
P2860
P2888
P304
P356
10.1038/NMETH.4535
P577
2017-12-11T00:00:00Z